Opaleye Management as of Dec. 31, 2013
Portfolio Holdings for Opaleye Management
Opaleye Management holds 23 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gentium S P A Sponsored Adr | 23.0 | $29M | 505k | 57.90 | |
| Geron Corporation (GERN) | 10.4 | $13M | 2.6M | 5.00 | |
| Pharmacyclics | 10.2 | $13M | 120k | 108.00 | |
| Ariad Pharmaceuticals | 9.3 | $12M | 1.7M | 7.10 | |
| NPS Pharmaceuticals | 4.7 | $5.9M | 205k | 29.00 | |
| Omeros Corporation (OMER) | 4.0 | $5.1M | 460k | 11.00 | |
| D Fluidigm Corp Del (LAB) | 4.0 | $5.0M | 133k | 38.00 | |
| Ligand Pharmaceuticals In (LGND) | 3.8 | $4.9M | 90k | 54.00 | |
| Cempra | 3.7 | $4.7M | 365k | 13.00 | |
| Cardiovascular Systems | 3.5 | $4.5M | 135k | 33.00 | |
| Sunshine Heart | 3.2 | $4.1M | 425k | 9.70 | |
| Intercept Pharmaceuticals In | 2.9 | $3.6M | 57k | 64.00 | |
| Inspiremd Com New | 2.3 | $2.9M | 1.1M | 2.60 | |
| Novadaq Technologies | 2.2 | $2.8M | 168k | 17.00 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.1 | $2.6M | 1.4M | 1.95 | |
| Celgene Corp Right 12/31/2030 | 1.8 | $2.2M | 800k | 2.80 | |
| Bind Therapeutics | 1.7 | $2.1M | 155k | 13.70 | |
| Biolinerx Sponsored Adr | 1.6 | $2.1M | 713k | 2.90 | |
| Tetraphase Pharmaceuticals | 1.6 | $2.0M | 154k | 13.00 | |
| Infinity Pharmaceuticals (INFIQ) | 1.3 | $1.7M | 130k | 12.85 | |
| Medivation | 1.3 | $1.6M | 25k | 64.00 | |
| Kalobios Pharmaceuticals | 0.9 | $1.2M | 285k | 4.10 | |
| Celator Pharmaceuticals | 0.8 | $961k | 310k | 3.10 |
